Heart Failure 2017: Face Failure
Some of the world’s greatest minds will focus on the heart this spring in Paris. Alere will be there, joining more than 6,100 healthcare professionals from more than 100 countries. Together, we’ll discuss strategies for a universal approach towards prevention and the treatment of heart failure.
Four days of scientific excellence
Despite all the advances made in long-term care, no new treatments for acute heart failure have emerged over the past two decades.1 Today, one in 10 patients with acute heart failure dies in hospital, and one in three dies within the year following an episode.1 Heart Failure 2017 is a time to raise awareness and stress the importance of accurate diagnosis and optimal treatment — starting with closing the gap between the guidelines we set and our practice.
Let’s talk about closing the gap between the guidelines and practice.
Time is muscle in acute heart failure: diagnose, treat and prevent!
Date & Time: Sunday, 30 April 1.00 - 2.30pm
This is a Lunch & Learn Session about the time to therapy concept for acute heart failure, which is now recommended by the new ESC guidelines. How can the journey of those patients be managed in daily practice?
Department of Cardiology
Cardiovascular Research Institute Basel (CRIB) University Hospital, Basel, Switzerland
Cardiology Unit, Cardio-Thoracic Department Policlinic of Bari, University of Bari, Italy
Best practice for discharge and follow up of patients hospitalized with acute heart failure
Role of natriuretic peptides and point-of-care testing.
Date & Time: Monday, 1 May 1.00 - 2.30pm
Acute heart failure patients still experience a high readmission and mortality rate after discharge. In this Lunch & Learn Session, experiences will be shared on how to improve the outcome of these patients with proper discharge planning and follow up management.
Department of Cardiology, St Vincent´s University Hospital, Dublin, Ireland
Heart Failure Unit CHR Dubos Pontoise Hospital, Pontoise, France
Date 1: Sunday, 30 April 3.00 – 5.00pm &
Date 2: Monday, 1 May 3.00 – 5.00pm
Please join us to find out how Near to Patient Testing can provide clinical, operational and economic benefits. In this Hands-on Tutorial we will demo our point-of-care solutions for Heart Failure, Acute Coronary Syndrome, Diabetes, and Blood Gas Testing. Come and get your own results!
Acute Heart Failure urgently requires rapid diagnosis and appropriate treatment
Come into the ER with chest pains, and attending physicians have well-established and proven pathways and processes to inform their diagnosis. It’s a different experience when you have shortness of breath. There are many possible causes, including asthma, chronic obstructed pulmonary disease, and pneumonia. Each is hard to differentiate from heart failure — and each requires different treatment.
Because Natriuretic Peptides have been shown to enhance diagnostic accuracy of acute heart failure in recent studies, we think BNP levels should be measured in all patients with acute dyspnea and suspected acute heart failure immediately upon admittance to the ED. The faster the diagnosis, the shorter the hospital stay and the lower the costs. The challenge is to make early diagnosis and the coordination of interdisciplinary care the accepted best practice everywhere — and ensure practice follows policy.
Make a heart failure diagnosis in minutes. Make a profound impact on your patient’s health.
Accurate and easy-to-use, Alere Triage® BNP Test helps you diagnose heart failure, determine the severity of the condition, and the risk stratification of the patients with acute coronary syndromes.
Add objective data to your assessment with in-office BNP testing.
As a primary care provider, you offer the first line of defense in the fight against heart failure. Alere Triage® NT-pro BNP offers early identification for your at-risk patients at the point of care or in the laboratory by measuring NT-proBNP.2